SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : TAVA Technologies (TAVA-NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RAVEL who wrote (25947)12/29/1998 8:36:00 PM
From: RAVEL  Read Replies (3) of 31646
 
Here it is...+FDA Warns Some Medical Devices May Malfunction Jan. 1, 1999

20:24:13, 29 December 1998


--------------------------------------------------------------------------------
Dow Jones News Service via Dow Jones

(MORE) DOW JONES NEWS 12-29-98

07:36 PM

- - 07 36 PM EST 12-29-98
:TICKER: HWP SAFE
:SUBJECT: FEQP FDA CA COMP INDG

Dow Jones News Service via Dow Jones

MINNEAPOLIS (Dow Jones)--The Food and Drug Administration said a defibrillator made by Hewlett-Packard Co. (HWP) and a patient monitor made by Invivo Corp.'s (SAFE) Invivo Research Inc. unit may not work properly after Dec. 31, 1998.

In a press release Tuesday, the FDA said these devices are among 15 from seven manufacturers that may have computer date bug problems as of Jan. 1, 1999.

The FDA said this information comes from an electronic message forum operated by Rx2000 Solutions Institute, a Minneapolis member-supported organization that is helping the U.S. health care system prepare for Year 2000 computer problems.

The FDA has worked with all seven manufacturers of the 15 devices, although only Hewlett-Packard and Invivo Research have confirmed that some aspects of the problems could occur.

The defibrillator and the patient monitor will work properly in direct use after Dec. 31, 1999, however they may not display, print or store the correct time and date of use of the devices.

These potential defects do not present an immediate risk to patients, but they can create the potential for confusion and incorrect records, the FDA said.


Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News